Status:
RECRUITING
Study of Biomarkers in Diabetic Chronic Wounds
Lead Sponsor:
Yibing Wang
Conditions:
Diabetes Mellitus
Biomarker
Eligibility:
All Genders
18-75 years
Brief Summary
This study aims to discover, verify and evaluate the potential biomarkers with regard to the diagnosis, prognostic and/or prediction of diabetic chronic wounds.
Detailed Description
Investigators will conduct a multicenter prospective case control study consisting of three stages. In the first stage, investigators will collect clinical data and blood, urine and stool samples fro...
Eligibility Criteria
Inclusion
- Age between 18 and 75;
- Signed the informed consent form；
- Subjects in the ND group are the healthy participants without diabetes；
- Subjects in the NWD group are the diabetic participants without newly identified wounds；
- Subjects in the CWD group are the diabetic participants with chronic wounds
Exclusion
- With sever acute underlying diseases of the brain, heart, lungs, liver and/or kidney;
- No diabetes but combined with lower limb arterial stenosis, occlusion or other conditions affecting wound healing or other causes of wounds such as varicose veins in the lower limbs;
- Special exclusion criteria for blood, urine and stool samples taking.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
930 Patients enrolled
Trial Details
Trial ID
NCT05342740
Start Date
July 1 2023
End Date
December 1 2025
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
Jinan, Shandong, China, 250014